-
COMPARISON OF BENEFIT DESIGN FOR DIABETES MEDICATIONS BETWEEN CONVENTIONAL MEDICARE ADVANTAGE PLANS AND CHRONIC CONDITION SPECIAL NEEDS PLANS
Mar 18, 2026, 21:38 PM -
THE BLOCKBUSTER BATTLE IN OBESITY: DO NEWER SEMAGLUTIDE DOSES CLOSE THE GAP? A TIME-COURSE MODEL-BASED NMA
Mar 18, 2026, 21:38 PM -
TRENDS IN INPATIENT COSTS AND DRIVERS OF HIGH-COST HOSPITALIZATIONS AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF CLOSED-SYSTEM AND OPEN-SYSTEM INFUSION OF HUMAN SERUM ALBUMIN IN ICU PATIENTS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY AND OUTCOMES OF BISPECIFIC ANTIBODIES IN OLDER ADULTS
Mar 18, 2026, 21:38 PM -
THE DYNAMICS OF EXACERBATION-RELATED HEALTH-STATE TRANSITIONS IN UNCONTROLLED ASTHMA: A MARKOV-BASED MULTI-CRITERIA ANALYSIS
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
ANTIHYPERTENSIVE TREATMENT PATTERNS BEFORE AND DURING PREGNANCY AMONG WOMEN WITH CHRONIC HYPERTENSION: A REAL-WORLD EHR STUDY
Mar 18, 2026, 21:38 PM -
POST-DISCHARGE TREATMENT PATHWAYS AFTER IV THERAPY FOR COMPLICATED UTI INCLUDING ACUTE PYELONEPHRITIS: IMPLICATIONS FOR LENGTH OF STAY, COSTS, AND TREATMENT FAILURE
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF CONSOLIDATION DURVALUMAB VERSUS OSIMERTINIB IN PATIENTS WITH UNRESECTABLE, STAGE III, EGFR-MUTATED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH MULTIMORBIDITY (=2 CO-OCCURRING CONDITIONS IN AN INDIVIDUAL) AMONG UNITED STATES ADULTS WITH A DIAGNOSIS OF ASTHMA
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL AGENTS IN 2024
Mar 18, 2026, 21:38 PM -
COMPARING THECOSTEFFECTIVENESS OFONSITEBUPRENORPHINE TREATMENT VERSUSTREATMENT FACILITY REFERRALATHARM REDUCTION AGENCIES
Mar 18, 2026, 21:38 PM -
AVOIDABLE HYPERTENSIVE ADMISSIONS: ACUTE COMPLICATIONS AND HOSPITAL UTILIZATION IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN ASSOCIATED WITH SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
BALANCING PRIVACY AND USABILITY IN REAL-WORLD DATA FOR OLDER ADULTS
Mar 18, 2026, 21:38 PM -
THE INCIDENCE OF INTRAUTERINE ADHESIONS FOLLOWING POTENTIALLY ADHESIOGENIC PROCEDURES: A SYSTEMATIC LITERATURE REVIEW WITH META-ANALYSES
Mar 18, 2026, 21:38 PM
